Ad is loading...
MENU

XLO Xilio Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
XLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
XLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

XLO is expected to report earnings to rise 16.68% to -25 cents per share on February 26

Xilio Therapeutics XLO Stock Earnings Reports
Q4'24
Est.
$-0.26
Q3'24
Beat
by $0.03
Q2'24
Missed
by $0.01
Q1'24
Missed
by $0.51
Q4'23
Beat
by $0.07
The last earnings report on November 07 showed earnings per share of -21 cents, beating the estimate of -24 cents. With 407.92K shares outstanding, the current market capitalization sits at 45.72M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
828 Winter Street
Phone
+1 857 524-2466
Employees
73
Web
https://www.xiliotx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FRBA14.71-0.13
-0.88%
First Bank
SFL10.39-0.14
-1.33%
SFL Corp Ltd
EL63.75-1.08
-1.67%
Estee Lauder Companies (The)
LUCD0.99-0.02
-2.30%
Lucid Diagnostics
MATX160.65-3.90
-2.37%
Matsons

XLO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XLO has been loosely correlated with AVTX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if XLO jumps, then AVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XLO
1D Price
Change %
XLO100%
+8.64%
AVTX - XLO
35%
Loosely correlated
-7.94%
CRMD - XLO
31%
Poorly correlated
-6.09%
AXON - XLO
31%
Poorly correlated
-0.86%
VKTX - XLO
30%
Poorly correlated
-7.45%
AIMD - XLO
26%
Poorly correlated
-8.75%
More